-
Serum Proteome Profiling Identifies Early Markers of Therapeutic Response to Neoadjuvant Chemotherapy of Breast Cancer
Study
EGAS00001006228
-
Biomarker Data from KATHERINE: A Phase III Study of Adjuvant Trastuzumab Emtansine versus Trastuzumab in Patients with Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer
Study
EGAS00001006229
-
Salivary Gland Cancer TSO500 dataset
Study
EGAS00001006232
-
Genomics characterization of BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR
Study
EGAS00001006247
-
Accumulation of copy number alterations and clinical progression across advanced prostate cancer
Study
EGAS00001006251
-
The University of Hong Kong Gastric Cancer Organoids RHO Signaling Study
Study
EGAS00001006252
-
Germline sequencing
Study
EGAS00001006254
-
Germline variant analysis in childhood AML
Study
EGAS00001006276
-
Deep whole genome sequencing identifies recurrent genomic alterations in breast cancer cell lines and patient derived xenograft models
Study
EGAS00001006285
-
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
Study
EGAS00001006293